Code | CSB-EP860342HU2 |
Abbreviation | Recombinant Human PARK7 protein, partial |
MSDS | |
Size | $224 |
Order now | |
Image | |
Have Questions? | Leave a Message or Start an on-line Chat |
Introducing the Recombinant Human Parkinson Disease Protein 7 (PARK7), a vital tool for advancing your cancer research endeavors. PARK7, a multifunctional protein, is implicated in various cellular processes, including oxidative stress response, cell proliferation, and apoptosis. Its dysregulation has been linked to several cancer types and neurodegenerative diseases, such as Parkinson's disease.
Our Recombinant Human PARK7 protein is expressed in E. coli, ensuring high levels of stability and bioactivity. The protein encompasses a partial sequence (1-174aa) and features an N-terminal 6xHis-SUMO tag for efficient purification and detection. With a purity of greater than 90% as determined by SDS-PAGE, our PARK7 protein offers consistent performance across a wide range of experimental applications. Choose between liquid or lyophilized powder forms to suit your laboratory needs, and trust in our precision-engineered Recombinant Human PARK7 protein to provide reliable results for your cancer research.
There are currently no reviews for this product.